| Name | Title | Contact Details |
|---|---|---|
Diana Walsh |
Director, Sales Enablement | Profile |
Elina Vilk |
Chief Marketing Officer | Profile |
LATCH is currently shopping the sale of the assets to all interested parties.
Blue Habanaro, Inc. is a Mississauga, ON-based company in the Software & Internet sector.
Empowering businesses to build Multilingual Conversational AI voice bots for customer service automation and omnichannel analytics.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Ulticom, Inc. provides the telecommunications industry with signaling software that enables development and deployment of mobility, location, payment, switching and messaging services within wireless, Internet protocol (IP) and wireline networks.